Partial dose of Yellow Fever vaccine works in emergencies
UF researchers contributed to a clinical trial that found using one-fifth of a standard dose of yellow fever vaccine is an effective strategy for emergency outbreak scenarios.
UF researchers contributed to a clinical trial that found using one-fifth of a standard dose of yellow fever vaccine is an effective strategy for emergency outbreak scenarios.
UF researchers led a comprehensive study estimating the proportion of food- and waterborne diseases in the US attributable to five major transmission pathways.
A lack of coordination in measures to control COVID-19 may accelerate cyclical outbreaks, according to a team of UF researchers.
UF researchers ask how knowledge, attitudes and behaviors regarding the COVID-19 pandemic may affect infection rates, and the mental health, of children and their parents.
Infectious disease modeler and biostatistician Ira Longini is applying decades of experience to help design and analyze clinical trials to identify a safe and effective COVID-19 vaccine.
UF researchers sifted through several thousand studies on human coronaviruses related to the novel SARS-CoV-2 which causes COVID-19, with the goal of learning from the past to help shape the future.
New work from the lab of Tony Maurelli, associate chair of the department of environmental and global health in UF's College of Public Health and Health Professions, has solved a quirky mystery about parasitic bacteria that cause the sexually-transmitted disease known as Chlamydia.
When it comes to managing risks to food crops from pathogens, landscape connections may be just as key to the spread of diseases as are networked trade routes and a changing climate.
Two UF researchers collaborated with international colleagues to measure how an individual’s immunity to flu is shaped over a lifetime of exposures to multiple influenza viruses. The team devised new metrics to analyze a person’s antibody profile and how it changes over time.
A UF/EPI professor helped develop a model that estimates slightly more than half of COVID-19 transmission is due to people with no symptoms. A third or more of these cases would need to be isolated, in addition to most symptomatic cases, to quell the pandemic.